New models in largest breast cancer clinical trial in Oklahoma

June 12, 2017

A University of Oklahoma and Mercy Hospital Oklahoma City research team is set to begin the largest breast cancer clinical trial ever performed in Oklahoma. The team has developed new breast cancer risk prediction models based on a computer-aided image feature analysis scheme to identify patients who might have cancers that are not visible on mammography. After review of 2,000 imaging studies performed at Mercy over the past two years and refinement of the image analysis system, the clinical trial begins July 1, 2017, at the Mercy Breast Center.

Bin Zheng and Hong Liu, professors in the Gallogly College of Engineering, affiliates of the Stephenson School of Biomedical Engineering and members of the Stephenson Cancer Center, teamed with Dr. Alan Hollingsworth, medical director of the Mercy Breast Center, to develop and validate this unique model for identifying women who are excluded from current breast magnetic resonance imaging guidelines, but have a higher risk of developing mammography-occult or hidden cancers that can be detected by MRI. At the same time, the study will evaluate women with elevated lifetime risk, but who are in no imminent risk of developing image-detectable cancers.

"The goal is to significantly increase of breast MRI screenings based on the quantitative imaging markers rather than the existing epidemiology-based risk assessment approaches," said Zheng.

Over the next three years, the clinical trial will enroll 4,000 women with mammograms interpreted as normal according to best practice guidelines. These mammograms will be de-identified and sent electronically to Zheng and Liu at the OU Advanced Cancer Imaging Laboratory for analysis. The women with higher scores predicted by the risk model will qualify for the additional breast screening. Hollingsworth anticipates between 200 and 400 patients of the original 4,000 will qualify for a breast MRI.

"If we can demonstrate cancer detection rates of even five percent in this population, then we will have achieved a higher yield than any other method of selecting patients for breast MRI screening. Five percent is 10-fold the cancer detection rate of screening mammography. At five percent or greater, we have the potential to alter how we screen for breast cancer. Unlike research projects that might take a decade or longer from 'bench-to-bedside,' if we're successful, this study will have practice-changing implications," said Hollingsworth.

Participants in this study will be those women who routinely have their mammograms performed at Mercy Breast Center. If you are interested in learning more about the clinical trial, call 405.936.5455.

Explore further: Screening MRI benefits women at average risk of breast cancer

Related Stories

Screening MRI benefits women at average risk of breast cancer

February 21, 2017
MRI screening improves early diagnosis of breast cancer in all women-not only those at high risk-according to a new study from Germany published online in the journal Radiology.

3-D imaging improves breast cancer screening

November 9, 2016
What if breast cancers could be found earlier, lumps seen more clearly or the number of callbacks reduced? Three-dimensional breast imaging technology can do just that by increasing the accuracy of breast cancer screening ...

Study suggests breast density alone not a risk factor for cancer

December 2, 2015
Breast density may not be a strong independent factor for breast cancer risk, according to a new study presented today at the annual meeting of the Radiological Society of North America (RSNA).

Annual mammography with screening ultrasound may benefit women at increased risk of breast cancer

April 3, 2012
The addition of a screening ultrasound or magnetic resonance imaging (MRI) to annual mammography in women with an increased risk of breast cancer and dense breast tissue resulted in a higher rate of detection of incident ...

What to know if breast cancer runs in your family

October 7, 2014
Breast cancer is the second leading cause of death from cancer in women. A woman's lifetime risk of developing breast cancer is 12 percent (1 of every 8 women). Breast cancer risk is higher among women whose close blood relatives ...

About half of women may benefit from mammograms at 40: analysis

April 14, 2016
(HealthDay)—New research suggests that all women turning 40 should get a breast cancer risk assessment, since half of them may have risks that are high enough to warrant annual mammograms right away.

Recommended for you

New bowel cancer drug target discovered

October 17, 2017
Researchers at the Francis Crick Institute have discovered a new drug target for bowel cancer that is specific to tumour cells and therefore less toxic than conventional therapies.

Many pelvic tumors in women may have common origin—fallopian tubes

October 17, 2017
Most—and possibly all—ovarian cancers start, not in ovaries, but instead in the fallopian tubes attached to them.

Using artificial intelligence to improve early breast cancer detection

October 17, 2017
Every year 40,000 women die from breast cancer in the U.S. alone. When cancers are found early, they can often be cured. Mammograms are the best test available, but they're still imperfect and often result in false positive ...

Researchers find novel mechanism of resistance to anti-cancer drugs

October 17, 2017
The targeted anti-cancer therapies cetuximab and panitumumab are mainstays of treatment for advanced colorectal cancer, the second leading cause of cancer-related deaths in the United States. However, many patients have tumors ...

Biology of childhood brain tumor subtypes offers clues to precision treatments

October 17, 2017
Researchers investigating pediatric low-grade gliomas (PLGG), the most common type of brain tumor in children, have discovered key biological differences in how mutated genes combine with other genes to drive this childhood ...

New assay may boost targeted treatment of non-Hodgkin lymphoma

October 17, 2017
Diffuse large B-cell lymphoma (DLBCL) is an aggressive cancer and the most frequently diagnosed non-Hodgkin lymphoma worldwide (nearly 40% of cases). Recent advancements indicate that both the prognosis and choice of treatment ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.